Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: Computer simulation of serial measurements with goal-setting for analytical quality

Clinical Chemistry

Volumn 43, Issue 11, 1997, Pages 2175-2182

  Kjeldsen, Jens ^a   Lassen, Jens Flensted ^b,c   Petersen, Per Hyltoft ^a   Brandslund, Ivan ^c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LILLEBAELT HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULATION; ARTICLE; COMPUTER SIMULATION; DATA ANALYSIS; HUMAN; ORAL DRUG ADMINISTRATION; QUALITY CONTROL; THROMBOEMBOLISM; TREATMENT PLANNING;

EID: 0030719416     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.11.2175     Document Type: Article

References (17)

1. Hirsh J. Oral anticoagulant drugs [Review]. N Engl J Med 1991; 324:1865-75.
2. van-der-Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy: an analysis of risk factors. Arch Intern Med 1993;153:1557-62.
3. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989;i:175-8.
4. Mariani G, Manotti C, Dettori AG. A computerized regulation of dosage in oral anticoagulant therapy. Res Clin Lab 1990;20:119-25.
5. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1992;102:312S-26S.
6. Lassen JF, Brandslund I, Antonsen S. Determination of critical difference and probability of significant change in consecutive measurements of International Normalized Ratio (INR) from patients on oral anticoagulant therapy. Clin Chem 1995;41:444-7.
7. Jacobson G, Groth T, De Verdier CH. Pancreatic iso-amylase in serum as a diagnostic test in different clinical situations; a simulation study. Scand J Clin Lab Invest 1904;40(Suppl 155): 77-84.
8. Hørder M, Petersen PH, Groth T, Gerhardt W. Influence of analytical quality on the diagnostic power of a single S-CK B test in patients with suspected acute myocardial infarction. Scand J Clin Lab Invest 1980;40(Suppl 155):95-100.
9. Trimble IM, West M, Knapp MS, Pownall R, Smith AF. Detection of renal allograft rejection by computer. Br Med J Clin Res Ed 1983;286:1695-9.
10. Groth T. The role of formal biodynamic models in laboratory medicine. Scand J Clin Lab Invest 1984;44(Suppl 171):175-92.
11. Lassen JF, Kjeldsen J, Antonsen S, Petersen PH, Brandslund I. Interpretation of serial measurements of International Normalized Ratio for prothrombin time in monitoring oral anticoagulant therapy. Clin Chem 1995;41:1171-6.
12. Gebski V. SPIDA (Statistical Package for Interactive Data Analysis). NSW 2190, Australia: Macquarie University Statistical Laboratory, 1988:1-265.
13. Statistix v. 4.0. User's manual. St. Paul, MN: Analytical Software, 1992:1-319.
14. Lassen JF, Dahler-Eriksen BS, Kjeldsen J, Lund ED, Petersen PH, Brandslund I. Impact of random variation of International Normalized Ratio in monitoring oral anticoagulant therapy [Abstract]. Blood Coagul Fibrinolysis 1996;7:402.
15. Kirkwood B. Essentials of medical statistics. Oxford, UK: Blackwell Scientific Publications, 1989:234 pp.
16. Fraser CG. The application of theoretical goals based on biological variation data in proficiency testing. Arch Pathol Lab Med 1988; 112:404-15.
17. Kynde K, Raabo E. Ekstern kvalitetssikring af koagulationsanalyser i Norden. Resultater fra den første nordiske prøveudsendelse. Klin Kern Norden 1994;6:43-6.